Skip to main content
Equibles
VRNO logo

VRNO · Verano Holdings Corp. · Metrics

Track VRNO — free

Use VRNO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRNO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.20 +0.19 (+3.79%) At close · Nov 2 Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$402.60M
Shares
72.93M
Volume · Nov 2 132.14K Avg daily vol (3M) 113.6K

VRNO metrics

77 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.20
Market cap
$402.60M

Price action

20 metrics
Price change (1W)
+4.6%
Price change (30D)
-1.0%
Price change (3M)
-2.1%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
51.1%
Annualized volatility (3M)
50.0%
Beta
—
RSI (14D)
48.3
Price vs SMA 50
-7.0%
Price vs SMA 200
—
Avg volume (3M)
113,599
Relative volume
1.2
Average dollar volume
$640,869

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
72.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.8×
reciprocal yield 126.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 222.8%
P / book
0.6
reciprocal yield 177.2%
FCF yield
16.4%
TTM · current market cap
Buyback yield
—
P / FCF
6.1
reciprocal yield 16.4%
P / operating cash flow
3.4
reciprocal yield 29.5%
Earnings yield
-57.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.3×
reciprocal yield 79.6%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 75.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
98.6×
reciprocal yield 1.0%
EV / EBITDA historical average (5Y)
98.6×
reciprocal yield 1.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-29

Profitability

9 metrics
Gross margin
47.9%
Operating margin
-15.3%
Trailing 12 months
Net margin
-25.9%
Gross profit (TTM)
$404.41M
Operating profit (TTM)
−$129.43M
Net income (TTM)
−$218.71M
Trailing 12 months
Diluted EPS (TTM)
$-3.01
FCF margin
7.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$11.61
Gross profit per diluted share (TTM)
$5.55
Operating profit per diluted share (TTM)
$-1.79
EBITDA per diluted share (TTM)
$-0.17
Net income per diluted share (TTM)
$-3.02
Operating cash flow per diluted share (TTM)
$1.53
Free cash flow per diluted share (TTM)
$0.85
Capital expenditures per diluted share (TTM)
$0.68
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.16
Book value per share
$9.69

Growth

11 metrics
Revenue growth YoY
+4.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$845.15M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.1%
Year over year · more shares
Revenue CAGR (3Y)
-2.2%
Revenue CAGR (5Y)
+29.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+0.3%

Quality

14 metrics
Return on equity
-32.6%
Return on assets
-12.8%
Debt / equity
0.6
Current ratio
3.6
EBITDA (TTM)
−$11.69M
Free cash flow (TTM)
$62.34M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$288.12M
Latest balance sheet
Cash & equivalents
$102.05M
Total assets
$1.71B
Total debt
$390.18M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$111.72M
Capital expenditures (TTM)
$49.38M
R&D (TTM)
—
SG&A (TTM)
$348.71M
Stock compensation (TTM)
$11.35M
R&D / revenue
—
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
2
13F filer change QoQ
0
Institutional ownership
0.2%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+36.3%
Holder tenure
3.0
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
40 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1848416 CUSIP 92339H200 Visit website Investor relations